Hello Aasir, the biggest problem with Theranos was the strategy "Fake it, until you make it." Faking test results is a no-go. They also wanted to develop a pocket-size analyzer that would be able to detect any disease. That means that they either had to miniaturize all the proven methods and put them in one device or come up with their new one. And that didn't work.

We focus on the detection of antibodies and antigens thanks to a chemiluminescence immunoassay (CLIA) which is a proven method. To sum it up, we are not trying to bring a new methodology but we can bring miniaturization, automatization, and digitalization into preventive care. 😊